Skip to main content
OpenTrials

Clinical trial condition

Wet Macular Degeneration

Explore clinical trials studying Wet Macular Degeneration. Study availability and eligibility vary by location and protocol.

76 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Wet Macular Degeneration trial results

Completed

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03834753

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Tucson, Arizona, United States
  • Clinical Site Arcadia, California, United States
  • Clinical Site Beverly Hills, California, United States
  • Clinical Site Campbell, California, United States
View all 50 locations
View Trial Details
Completed

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03844074

Conditions
Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Clinical Site Hurstville, New South Wales, Australia
  • Clinical Site Liverpool, New South Wales, Australia
  • Clinical Site Sydney, New South Wales, Australia
  • Clinical Site Westmead, New South Wales, Australia
View Trial Details
Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

NCT04047472

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 30 locations
View Trial Details
Completed

A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD)

NCT03861234

Conditions
Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
Locations
  • Associated Retina Consultants, Ltd. Phoenix, Arizona, United States
  • New York Eye and Ear Infirmary of Mount Sinai New York, United States
  • Verum Research, LLC Eugene, Oregon, United States
  • Erie Retina Research, LLC Erie, Pennsylvania, United States
View all 14 locations
View Trial Details
Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

NCT04005352

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +17 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Loma Linda, California, United States
  • Novartis Investigative Site Riverside, California, United States
View all 118 locations
View Trial Details
Completed

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

NCT04832724

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +4 more
Locations
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Sun City, Arizona, United States
  • Retina Consultants of San Diego San Diego, California, United States
  • California Retina Consultants Santa Barbara, California, United States
View all 13 locations
View Trial Details
Completed

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

NCT03927690

Conditions
Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +22 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Rancho Cordova, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site ‘Aiea, Hawaii, United States
View all 22 locations
View Trial Details

Related conditions